GNAS and pancreatic intraductal papillary-mucinous neoplasm: Although present in all IPMN subtypes, GNAS mutations are significantly associated with the intestinal subtype (approximately 75% of cases) [77] and invasive colloid type lesions (found in 80–90% versus 15–30% in tubular carcinomas) [18,64,70].